APOE and Alzheimer disease: Finally, lower hippocampal volume at baseline and faster GM atrophy in APOE ε4 carriers were associated with accelerated OID decline, which may reflect an ongoing pathological process and early functional changes in a group that already presents a high AD genetic risk (Calhoun-Haney and Murphy, 2005; Mishra et al., 2018).